Friday, July 10, 2026

pharma · Vitiligo · Erythropoietic Protoporphyria (EPP)

CLINUVEL PHARMACEUTICALS

CLINUVEL PHARMACEUTICALS clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Melbourne, AU HQ
2001 Founded
83 Employees
EMA registrant Type
Company details
Status
Public
HQ
Melbourne, AU
Founded
2001
Employees
83
Programs
5
Drugs
3
Patents
0
Intelligence · Clinical Programs

CLINUVEL PHARMACEUTICALS projects

1 ClinicalTrials.gov programs sponsored by CLINUVEL PHARMACEUTICALS.

CLINUVEL PHARMACEUTICALS has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. SCENESSE 16 mg implant

    Clinuvel Europe Limited

    Vitiligo

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does CLINUVEL PHARMACEUTICALS have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.